Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
An open label phase I treatment trial (single group assignment) evaluating Anti-PD-1 antibodies / PD-1 inhibitors + Fecal Microbiota Transplantation (FMT) in patients with Gastrointestinal Cancers
Primary outcome measures:
Objective Response Rate (ORR)
Rate of abnormal vital signs and laboratory test results
The number of adverse events
…